Control of autoimmune diseases by the vitamin D endocrine system (Q37204961)

18 August 2017

1 reference

title

Control of autoimmune diseases by the vitamin D endocrine system (English)

1 reference

18 August 2017

0 references

0 references

Giuseppe Penna

2

0 references

author name string

Luciano Adorini

series ordinal

1

1 reference

18 August 2017

1 July 2008

1 reference

Nature Clinical Practice Rheumatology

18 August 2017

1 reference

18 August 2017

4

1 reference

18 August 2017

8

1 reference

18 August 2017

404-412

1 reference

https://scigraph.springernature.com/pub.10.1038/ncprheum0855

18 August 2017

0 references

cites work

Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0855

Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0855

Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0855

1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0855

Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0855

1,25-Dihydroxyvitamin D3 selectively modulates tolerogenic properties in myeloid but not plasmacytoid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0855

Transcriptional repression of the interleukin-2 gene by vitamin D3: direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0855

1alpha,25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0855

Treatment of experimental autoimmune prostatitis in nonobese diabetic mice by the vitamin D receptor agonist elocalcitol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0855

Topically applied 1,25-dihydroxyvitamin D3 enhances the suppressive activity of CD4+CD25+ cells in the draining lymph nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0855

A vitamin D analog down-regulates proinflammatory chemokine production by pancreatic islets inhibiting T cell recruitment and type 1 diabetes development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0855

IL-10 signaling is essential for 1,25-dihydroxyvitamin D3-mediated inhibition of experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0855

Vitamin D: its role and uses in immunology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0855

7 January 2021

Vitamin D and its analogs as regulators of immune activation and antigen presentation

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0855

7 January 2021

Intervention in autoimmunity: the potential of vitamin D receptor agonists

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0855

7 January 2021

Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0855

7 January 2021

Vitamin D and autoimmunity: new aetiological and therapeutic considerations

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0855

7 January 2021

Vitamin D and its role in immunology: multiple sclerosis, and inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0855

7 January 2021

Pharmacological induction of tolerogenic dendritic cells and regulatory T cells.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0855

7 January 2021

Identification and immune regulation of 25-hydroxyvitamin D-1-alpha-hydroxylase in murine macrophages

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0855

7 January 2021

Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0855

7 January 2021

DCs metabolize sunlight-induced vitamin D3 to 'program' T cell attraction to the epidermal chemokine CCL27

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0855

7 January 2021

1,25(OH)2D2 production by T lymphocytes and alveolar macrophages recovered by lavage from normocalcemic patients with tuberculosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0855

7 January 2021

https://api.crossref.org/works/10.1038%2FNCPRHEUM0855

1 reference

7 January 2021

Current understanding of the function of the nuclear vitamin D receptor in response to its natural and synthetic ligands.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0855

7 January 2021

Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0855

7 January 2021

Expression of the inhibitory receptor ILT3 on dendritic cells is dispensable for induction of CD4+Foxp3+ regulatory T cells by 1,25-dihydroxyvitamin D3.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0855

7 January 2021

Dendritic cell modulation by 1alpha,25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0855

7 January 2021

Regulation of relB in dendritic cells by means of modulated association of vitamin D receptor and histone deacetylase 3 with the promoter.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0855

7 January 2021

IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0855

7 January 2021

Inhibition of Th1 development and treatment of chronic-relapsing experimental allergic encephalomyelitis by a non-hypercalcemic analogue of 1,25-dihydroxyvitamin D(3)

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0855

7 January 2021

Vitamin D3: a transcriptional modulator of the interferon-gamma gene

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0855

7 January 2021

The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0855

7 January 2021

A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0855

7 January 2021

A 1alpha,25-dihydroxyvitamin D(3) analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0855

7 January 2021

In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0855

7 January 2021

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0855

7 January 2021

Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0855

7 January 2021

Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0855

7 January 2021

Epidemiology of disease risks in relation to vitamin D insufficiency

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0855

7 January 2021

Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0855

7 January 2021

The role of vitamin D in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0855

7 January 2021

Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0855

7 January 2021

Vitamin D supplementation in early childhood and risk of type 1 diabetes: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0855

7 January 2021

Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0855

7 January 2021

Vitamin D deficiency in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0855

7 January 2021

Vitamin D intake and risks of systemic lupus erythematosus and rheumatoid arthritis in women

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0855

7 January 2021

Report on the vitamin D status of adult and pediatric patients with inflammatory bowel disease and its significance for bone health and disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0855

7 January 2021

Genetics and biology of vitamin D receptor polymorphisms

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0855

7 January 2021

Vitamin D receptor polymorphisms and diseases

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0855

7 January 2021

Noncalcemic Actions of Vitamin D Receptor Ligands

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0855

7 January 2021

Current and future management of psoriasis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0855

7 January 2021

Identification and characterization of noncalcemic, tissue-selective, nonsecosteroidal vitamin D receptor modulators.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0855

7 January 2021

1,25-Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0855

7 January 2021

A vitamin D analogue (MC 1288) has immunomodulatory properties and suppresses collagen-induced arthritis (CIA) without causing hypercalcaemia

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0855

7 January 2021

The effects of 1 alpha,25-dihydroxyvitamin D(3) on matrix metalloproteinase and prostaglandin E(2) production by cells of the rheumatoid lesion

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0855

7 January 2021

Vitamin D in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0855

7 January 2021

Genetic basis of murine lupus.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0855

7 January 2021

Prevention of immunological disorders in MRL/l mice by a new synthetic analogue of vitamin D3: 22-oxa-1 alpha,25-dihydroxyvitamin D3

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0855

7 January 2021

1,25-Dihydroxyvitamin D3 attenuates the expression of experimental murine lupus of MRL/l mice

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0855

7 January 2021

Vitamin D(3) and its synthetic analogs inhibit the spontaneous in vitro immunoglobulin production by SLE-derived PBMC.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0855

7 January 2021

Unaltered diabetes presentation in NOD mice lacking the vitamin D receptor

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0855

7 January 2021

1,25 dihydroxyvitamin-D3 modulates JAK–STAT pathway in IL-12/IFNγ axis leading to Th1 response in experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0855

7 January 2021

Vitamin D and the vitamin D receptor are critical for control of the innate immune response to colonic injury

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0855

7 January 2021

Calcium and 1 alpha,25-dihydroxyvitamin D3 target the TNF-alpha pathway to suppress experimental inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0855

7 January 2021

Mechanisms in prostatitis/chronic pelvic pain syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0855

7 January 2021

Inhibition of prostate cell growth by BXL-628, a calcitriol analogue selected for a phase II clinical trial in patients with benign prostate hyperplasia.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0855

7 January 2021

The vitamin D receptor as a therapeutic target

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0855

7 January 2021

Vitamin D and its analogues: do they protect against cardiovascular disease in patients with kidney disease?

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0855

7 January 2021

Vitamin D and cardiovascular disease risk

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0855

7 January 2021

Identifiers

DOI

10.1038/NCPRHEUM0855

1 reference

PubMed ID

18594491

Dimensions Publication ID

18 August 2017

0 references

1 reference

PubMed ID

18594491